COVID-19 outcomes in patients with hematologic disease-Reference-Cited by-同舟云学术

COVID-19 outcomes in patients with hematologic disease

Published:2020-05-06 Issue:11 Volume:55 Page:2180-2184
ISSN:0268-3369
Container-title:Bone Marrow Transplantation
language:en
Short-container-title:Bone Marrow Transplant

Author:

Malard Florent^ORCID,Genthon Alexis,Brissot Eolia,van de Wyngaert Zoe^ORCID,Marjanovic Zora,Ikhlef Souhila,Banet Anne,Lapusan Simona,Sestilli Simona,Corre Elise,Paviglianiti Annalisa,Adaeva Rosa,M.’Hammedi-Bouzina Fella,Labopin Myriam,Legrand Ollivier,Dulery Rémy,Mohty Mohamad

Publisher

Springer Science and Business Media LLC

Subject

Transplantation,Hematology

Link

http://www.nature.com/articles/s41409-020-0931-4.pdf

Reference12 articles.

1. Guan WJ, Ni ZY, Hu Y, Liang WH, Ou CQ, He JX, et al. Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med. 2020;382:1708–20.

2. Yang X, Yu Y, Xu J, Shu H, Xia J, Liu H, et al. Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study. Lancet Respir Med. 2020. In press.

3. Lauer SA, Grantz KH, Bi Q, Jones FK, Zheng Q, Meredith HR, et al. The incubation period of coronavirus disease 2019 (COVID-19) from publicly reported confirmed cases: estimation and application. Ann Intern Med. 2020. In press.

4. Koo JR, Cook AR, Park M, Sun Y, Sun H, Lim JT, et al. Interventions to mitigate early spread of SARS-CoV-2 in Singapore: a modelling study. Lancet Infect Dis. 2020. In press.

5. Liang W, Guan W, Chen R, Wang W, Li J, Xu K, et al. Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China. Lancet Oncol. 2020;21:335–7.

Cited by 141 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy and safety of venetoclax in relapsed/refractory chronic lymphocytic leukemia in Russia routine clinical practice;Oncohematology;2024-09-01

2. Assessing the impact of COVID-19 on acute leukemia patients: a comparative analysis of hematological and biochemical parameters;BMC Infectious Diseases;2024-06-11

3. The patients with multiple myeloma were infected with COVID-19 during autologous stem cell transplantation: case report and literature review;Infectious Agents and Cancer;2024-05-27

4. COVID‐19 outcomes in haemopoietic stem cell transplant recipients in Western Australia: the value of vaccination and antiviral therapy;Internal Medicine Journal;2024-04

5. Impact of COVID-19 on Patients with Beta-Thalassemia <i>Major</i>: An Observational Study;Acta Haematologica;2024-02-28